Having failed to meet its year-end 2014 target date, FDA is now eyeing 2015 to issue guidance governing pharmaceutical sponsors’ interactions with formulary committees on health care economic information.
In a Dec. 22 letter to two law firms that represent the Medical Information Working Group (MIWG), Associate Commissioner for Policy Leslie Kux said the agency’s current goal...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?